Product Number |
OAAB16953 |
Product Page |
www.avivasysbio.com/rbks-rbsk-antibody-n-terminal-region-oaab16953.html |
Name |
RBKS Antibody - N-terminal region (OAAB16953) |
Molecular Weight |
34143 Da |
Isotype |
Ig |
NCBI Gene Id |
64080 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
Approximately 0.5mg/ml. Actual concentration varies with each lot. |
Alias Symbols |
RK, RBSK |
Product Format |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
Description of Target |
Purified Rabbit Polyclonal Antibody (Pab) |
Reconstitution and Storage |
Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for OAAB16953 |
Additional Information |
Precautions: RBKS (RBSK) Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Application Info |
WB: 1:1000 IHC-P: 1:50~100 |
Immunogen |
This RBKS (RBSK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 16-46 amino acids from the N-terminal region of human RBKS (RBSK). |
Uniprot ID |
Q9H477 |
Protein Name |
Ribokinase |
Sample Type Confirmation |
RBKS is strongly supported by BioGPS gene expression data to be expressed in HepG2 |
Protein Accession # |
NP_071411.1 |
Gene Symbol |
RBKS |
Predicted Species Reactivity |
Human |
Application |
WB, IHC |
Predicted Homology Based on Immunogen Sequence |
Human |
Image 1 | HepG2
| Western blot analysis of anti-RBSK Pab(Cat. # OAAB16953) in HepG2 cell line lysate (35ug/lane). RBSK(arrow) was detected using the purified Pab (1:40 dilution). RBKS is strongly supported by BioGPS gene expression data to be expressed in HepG2 |
| Image 2 | hepatocarcinoma
| Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma. |
|
|